Publications and Presentations

Export 591 results:
Sort by: Author Title [ Type [desc]] Year
Poster Presentation
Ryan A, Smith SM, Cummins V, Murphy CM, Galvin R. Activ8: an Interagency Physical Activity and Lifestyle Programme for Multimorbidity. SPHeRE Conference, Dublin, January 2018.; 2018.
Murphy M, Byrne M, Boland F, Corrigan D, Fahey T, Smith SM. Supporting GP-led therapeutic actions for patients with poorly-controlled type 2 diabetes mellitus (the DECIDE study); feasibility study and protocol for a pilot cluster randomised controlled trial. SAPC ASM, London, July 2018.; 2018.
Murphy M, Fahey T. Conflicts of interest in one Irish academic publication and a comparison with voluntary declarations of pharmaceutical payments. SAPC ASM, London, July 2018.; 2018.
Moriarty F, Razzaque S, McDowell R, Fahey T. Prescribing variation in English primary care following a regulatory safety warning on mirabegron. International Conference on Pharmacoepidemiology and Therapeutic Risk Management, ICPE, Prague, 22-26 August 2018.; 2018.
McCarthy C, Clyne B, Smith SM. Baseline characteristics and repeat prescribing policies of general practices recruited to the SPPiRE trial(Poster Pitch presented by Susan Smith). SAPC ASM, London, July 2018.; 2018.
Cardwell K, Clyne B, Moriarty F, Wallace E, Fahey T, Boland F, et al. Supporting prescribing in Irish primary care: Protocol for a non‐randomised pilot study of a General Practice Pharmacist (GPP) intervention to optimise prescribing in primary care. HSRPP, University of Newcastle, 12th-13th April 2018.; 2018.
Moriarty F, Bennett K, Fahey T. Trends in opioid and analgesic utilisation in Ireland from 2000 to 2015. International Conference on Pharmacoepidemiology and Therapeutic Risk Management, ICPE, Prague, 22-26 August 2018.; 2018.
Moriarty F, Razzaque S, McDowell R, Fahey T. Prescribing variation in English primary care following a regulatory safety warning on mirabegron. SAPC ASM, London, July 2018.; 2018.
Cardwell K, Clyne B, Moriarty F, Wallace E, Fahey T, Boland F, et al. Supporting prescribing in Irish primary care: Protocol for a non‐randomised pilot study of a General Practice Pharmacist (GPP) intervention to optimise prescribing in primary care. RCSI Research Day, 7th March 2018.; 2018.
Clyne B, Boland F, Murphy N, Murphy E, Moriarty F, Wallace E, et al. Randomised controlled trials in Irish Health Research: a systematic review. SAPC ASM, London, July 2018.; 2018.
Machikan A, Moriarty F, McDowell R, Fahey T, Clyne B. Adverse drug reactions as a cause of hospital admission in older patients in Ireland: a descriptive cohort. RCSI Research Day, 7th March 2018.; 2018.
Moriarty F, Bennett K, Cahir C, Fahey T. Evaluating the economic impact of potentially inappropriate prescribing in older people in Ireland using a Markov modelling approach. RCSI Research Day, 7th March 2018.; 2018.
Redmond P, McDowell R, Grimes T, Boland F, McDonnell R, Hughes CM, et al. Unintended discontinuation of chronic medication following hospitalisation: a retrospective cohort study. SAPC ASM, London, July 2018. (Presented by Moriarty F).; 2018.
Razzaque S, Moriarty F, McDowell R, Fahey T. Prescribing variation in English primary care following a regulatory safety warning on mirabegron. RCSI Research Day, 7th March 2018.; 2018.
Cardwell K, Clyne B, Moriarty F, Wallace E, Fahey T, Smith SM. Supporting prescribing in Irish primary care: Protocol for non-randomized pilot study of General Practice Pharmacist (GPP) Intervention to optimize prescribing in Primary Care. North American Primary Care Research Group (NAPCRG), Montreal, November 2017.; 2017.
Cardwell K, Clyne B, Moriarty F, Wallace E, Fahey T, Smith SM, et al. Supporting prescribing in Irish primary care: Protocol for non-randomized pilot study of General Practice Pharmacist (GPP) Intervention to optimize prescribing in Primary Care. NAPCRG, Montreal. November 2017 .; 2017.
Ryan A, Smith SM, Cummins V, Murphy CM, Galvin R. Activ8: an Interagency Physical Activity and Lifestyle Programme for Multimorbidity. Falls, Frailty & Bone Health Congress, Dublin, November 2017.; 2017.
McCarthy C, Clyne B, Corrigan D, Boland F, Wallace E, Moriarty F, et al. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot. Implementation science. NAPCRG. Montreal, November 2017.; 2017.
Byrne P, Cullinan J, Murphy CM, Smith SM. Who use statins and why? A cross-sectional analysis of statin utilisation in the context of cardiovascular risk and socio-demographic factors. SPHeRE 3rd Annual Conference, RCSI, Dublin, 12th January 2017 - Winner of Best Poster.; 2017.
Alabi O, Munir K, Redmond P, McDowell R, Dockeray L, Fahey T. Potentially inappropriate prescribing, comorbidity and hospitalisation in older patients in an Irish general practice. Poster Presentation. RCSI Research Day,February 2016.; 2016.
Moriarty F, Bennett K, Cahir C, Kenny RA, Fahey T. Potentially inappropriate prescribing measured by STOPP and START and functional decline and quality of life in older people: a cohort study. RCSI School of Postgraduate Studies 10 Year Anniversary Conference, RCSI, September 9, 2016..; 2016.
Murphy M, Galvin R, Fahey T, Byrne M, Smith SM. Effectiveness of interventions in primary care to improve glycated haemoglobin and cardiovascular risk factor levels in patients with poorly-controlled type 2 diabetes mellitus: a systematic review.SAPC 6th-8th of July 2016 Dublin Castle/RCSI.. .; 2016.
Murphy M, Bennett K, Fahey T, Smith SM. Variation in prescribing of anti-diabetic medications, including newer injectable medications, in Ireland in 2013 and 2014. RCSI Research Day 25th February 2016.; 2016.
Harrington E, Wesseling N, Clyne B, Sandu H, Armstrong L, Bennett H, et al. Predicting malignant melanoma in primary care: a systematic review of clinical prediction rules. RCSI Research Day February 2016, Dublin.; 2016.
Moriarty F, Bennett K, Cahir C, Fahey T. Evaluating the economic impact of potentially inappropriate prescribing in older people in Ireland using a Markov modelling approach. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) European Congress; 31st October 2016..; 2016.

Pages